The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • No CSPEC related information was provided by the message!

  • See Evidence submitted by expert panel for details.

Variant: NM_000018.4(ACADVL):c.932del (p.Phe311fs)

CA8337906

554546 (ClinVar)

Gene: ACADVL
Condition: very long chain acyl-CoA dehydrogenase deficiency
Inheritance Mode: Autosomal recessive inheritance
UUID: c0016a2e-1713-4d16-915e-ab1704ff5383

HGVS expressions

NM_000018.4:c.932del
NM_000018.4(ACADVL):c.932del (p.Phe311fs)
NC_000017.11:g.7222720del
CM000679.2:g.7222720del
NC_000017.10:g.7126039del
CM000679.1:g.7126039del
NC_000017.9:g.7066763del
NG_007975.1:g.7887del
NG_008391.2:g.2332del
ENST00000356839.10:c.932del
ENST00000322910.9:c.*887del
ENST00000350303.9:c.866del
ENST00000356839.9:c.932del
ENST00000543245.6:c.1001del
ENST00000578824.5:n.81del
ENST00000581378.5:c.650del
ENST00000582379.1:n.316del
NM_000018.3:c.932del
NM_001033859.2:c.866del
NM_001270447.1:c.1001del
NM_001270448.1:c.704del
NM_001033859.3:c.866del
NM_001270447.2:c.1001del
NM_001270448.2:c.704del

Likely Pathogenic

Met criteria codes 2
PVS1 PM2_Supporting

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ACADVL VCEP
NM_000018.4(ACADVL):c.932del (p.Phe311SerfsTer42) variant in ACADVL is a frameshift variant predicted cause a premature stop codon in biologically-relevant-exon 10/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124). The highest population minor allele frequency in gnomAD v2.1.1 is 0.000009 in non-Finnish European population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting). At least one individual with this variant was identified by very long chain acyl-CoA dehydrogenase (VLCAD) clinical phenotype, who also carried a pathogenic splicing variant c.623-1G>A in trans, but this information is insufficient for to use toward classification (PMID: 10077518). In summary, this variant meets the criteria to be classified as likely pathogenic for autosomal recessive very long chain acyl-CoA dehydrogenase (VLCAD) deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen ACADVL Variant Curation Expert Panel: PVS1, PM2_Supporting.
Met criteria codes
PVS1
NM_000018.4(ACADVL):c.932del (p.Phe311SerfsTer42) variant in ACADVL is a frameshift variant predicted cause a premature stop codon in biologically-relevant-exon 10/20 leading to nonsense mediated decay in a gene in which loss-of-function is an established disease mechanism (PVS1; PMIDs 9973285, 11590124).
PM2_Supporting
The highest population minor allele frequency in gnomAD v2.1.1 is 0.000009 in non-Finnish European population, which is lower than the ClinGen ACADVL Variant Curation Expert Panel threshold (<0.001) for PM2_Supporting, meeting this criterion (PM2_Supporting).
Approved on: 2023-09-26
Published on: 2023-09-26
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.